PNC Financial Services Group
SION

PNC Financial Services Group’s Sionna Therapeutics SION Stock Holding History

PNC Financial Services Group’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220 Sell
5
-11
-69% -$440 ﹤0.01% 5093
2026
Q1 		$641 Buy
16
+11
+220% +$420 ﹤0.01% 4857
2025
Q4 		$206 Hold
5
– – ﹤0.01% 4976
2025
Q3 		$147 Buy
+5
New +$109 ﹤0.01% 4966

Other funds holding SION

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PNC Financial Services Group's SION Position: Q2 2026 in Review

PNC Financial Services Group reduced its Sionna Therapeutics (SION) stake by 69% in Q2 2026, selling an estimated $440 and leaving 5 shares worth $220. The position accounts for ﹤0.01% of the portfolio, ranked #5093.

PNC Financial Services Group first reported a position in SION in Q3 2025 and has held it in 4 quarters since. The position peaked at $641 in Q1 2026. 146 funds tracked by Wall St. Rank hold SION as of Q2 2026.

  • PNC Financial Services Group held 5 shares of Sionna Therapeutics worth $220 as of Q2 2026.
  • PNC Financial Services Group sold 11 Sionna Therapeutics shares in Q2 2026, an estimated $440.
  • Sionna Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5093 holding.
  • PNC Financial Services Group first reported a position in Sionna Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • PNC Financial Services Group's Sionna Therapeutics position peaked at $641 in Q1 2026.
  • 146 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.